Camurati-Engelmann Disease
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Camurati-Engelmann Disease

What is the definition of Camurati-Engelmann Disease?

Camurati-Engelmann disease is a skeletal condition that is characterized by abnormally thick bones (hyperostosis) in the arms, legs, and skull.

What are the causes of Camurati-Engelmann Disease?

Mutations in the TGFB1 gene cause Camurati-Engelmann disease. The TGFB1 gene provides instructions for producing a protein called transforming growth factor beta-1 (TGFβ-1). The TGFβ-1 protein triggers chemical signals that regulate various cell activities, including the growth and division (proliferation) of cells, the maturation of cells to carry out specific functions (differentiation), cell movement (motility), and controlled cell death (apoptosis).

How prevalent is Camurati-Engelmann Disease?

The prevalence of Camurati-Engelmann disease is unknown. More than 300 cases have been reported worldwide.

Is Camurati-Engelmann Disease an inherited disorder?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Who are the top Camurati-Engelmann Disease Local Doctors?
Distinguished in Camurati-Engelmann Disease
Holistic Medicine
Distinguished in Camurati-Engelmann Disease
Holistic Medicine
14480 Sanford Ave Apt 6l, 
Flushing, NY 
Languages Spoken:
English

Qian Li is a Holistic Medicine provider practicing medicine in Flushing, New York. Mr. Li is rated as a Distinguished provider by MediFind in the treatment of Camurati-Engelmann Disease. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Bietti Crystalline Dystrophy (BCD), Melioidosis, Camurati-Engelmann Disease, Endoscopy, and Hepatectomy.

Advanced in Camurati-Engelmann Disease
Advanced in Camurati-Engelmann Disease

St. Michael Cancer Center

1900 Northwest Myhre Road, 
Silverdale, WA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Jacob Mathew, MD is a fellowship trained, board-certified hematologist/oncologist who believes we are born with essential dignity and his goal is to preserve that dignity, at times using his medical knowledge and at other times just being there for his fellow man. Dr. Mathew believes that the practice of medicine should be evidence-based while simultaneously incorporating the art of medicine. To him, the art of medicine means he needs to be the advocate for his patients. He also hopes to empower his patients to play a pivotal role in their medical care and decision making by teaching them at least the basics of their disease. Dr. Mathew is rated as an Advanced provider by MediFind in the treatment of Camurati-Engelmann Disease. He is also highly rated in 85 other conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Osteotomy, and Bone Marrow Aspiration. Dr. Mathew is board certified in Hematology and Medical Oncology. Dr. Mathew is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Camurati-Engelmann Disease
Pain Medicine
Advanced in Camurati-Engelmann Disease
Pain Medicine

Trinity Clinic

619 S. Fleishel Ave., Suite 305, 
Tyler, TX 
Languages Spoken:
English, Spanish

Neil Adelman is a Pain Medicine provider practicing medicine in Tyler, Texas. Dr. Adelman is rated as an Advanced provider by MediFind in the treatment of Camurati-Engelmann Disease. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Ribbing Disease, Camurati-Engelmann Disease, Phantom Limb Pain, and Pudendal Neuralgia. Dr. Adelman is board certified in American Board Of Internal Medicine.

What are the latest Camurati-Engelmann Disease Clinical Trials?
Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy

Summary: The understanding of ARVC pathophysiology remains incomplete. Several clues indicate that disease progression is mediated through inflammation. The present study aim to document the feasibility of detecting the potential presence of intracardiac local inflammatory components in patients with ARVC.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: November 01, 2017
Published By: National Institutes of Health